Serum Protein Markers May Aid in RCC Detection and Prognosis | GU Oncology Now
For the study, researchers identified potential protein biomarkers for diagnosing and prognosticating renal cell carcinoma.
Related Articles
A pole dancer’s journey from meat-eating athlete to vegan pastry chef
This month is Veganuary, a good time to try a plant-based diet. A convert, and experts, describe its many health benefits.
The 15 Safest Countries To Travel, Ranked In A New Report
Searching for the safest countries to visit? An annual report ranks the safest countries in the world—with Iceland coming out on top. The U.S. didn’t…
Miniature Implantable Left Atrial/Ventricular Pump to Treat Symptoms of Heart Failure With Preserved Ejection Fraction: A Novel Device Treatment
Tissue Engineering Research Group, RCSI University of Medicine and Health Sciences, Dublin, Ireland Pumpinheart Ltd, Galway, Ireland Tissue Engineering Research Group, RCSI University of Medicine…
Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failure
Gauthier and colleagues evaluated concomitant ibrutinib and anti-CD19 chimeric antigen receptor (CAR) T-cell therapy in a study of patients with chronic ly
Podcasts on Nephrology Times | Docwire News
Nephrology Times is proud to feature Freely Filtered and Channel Your Enthusiasm, leading health care podcasts covering the latest research in the nephrology space.
Allogeneic Hematopoietic Stem Cell Transplantation in R/R B-Cell Non-Hodgkin Lymphoma | Blood Cancers Today
While CAR-T cell therapy has emerged as a transformative salvage option for around 40% of patients, long-term data on allo-HSCT remain sparse, research shows.
Oncology Society Urges Americans to Heed Surgeon General Advisory on
The U.S. Surgeon General’s office released a new advisory on the link between alcohol consumption and increased risk for cancer. The advisory reports alcohol use…
The good, the bad and the ugly at the end of Michigan’s Democratic trifecta
And a bit of hope for 2025
Ferring Advances Clinical Trials for ADSTILADRIN in Bladder and Upper Tract Urothelial Cancers | GU Oncology Now
Ferring has advanced three clinical trials assessing nadofaragene as a monotherapy and combination therapy for NMIBC.
Electrocardiogram-Based Deep Learning to Predict Mortality in Repaired Tetralogy of Fallot:
AbstractBackgroundArtificial intelligence–enhanced electrocardiogram (AI-ECG) analysis shows promise to predict mortality in adults with acquired cardiovascular diseases. However, its application t…